903 related articles for article (PubMed ID: 16476869)
1. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
[TBL] [Abstract][Full Text] [Related]
2. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
Beaton M; Adams PC
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
[TBL] [Abstract][Full Text] [Related]
3. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
4. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
Adams PC
Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
[TBL] [Abstract][Full Text] [Related]
5. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.
Adams PC; Deugnier Y; Moirand R; Brissot P
Hepatology; 1997 Jan; 25(1):162-6. PubMed ID: 8985284
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
Bassett ML; Halliday JW; Ferris RA; Powell LW
Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
[TBL] [Abstract][Full Text] [Related]
7. [Primary hemochromatosis in asymptomatic young patients].
Muñoz Sánchez MM; Núñez Martínez O; Torres Orgaz A; del Castillo Rueda A; de Portugal Alvarez J
An Med Interna; 2000 Jan; 17(1):9-12. PubMed ID: 10730398
[TBL] [Abstract][Full Text] [Related]
8. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
[TBL] [Abstract][Full Text] [Related]
9. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of hemochromatosis.
O'Neil J; Powell L
Semin Liver Dis; 2005 Nov; 25(4):381-91. PubMed ID: 16315132
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
12. Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred.
Rowe JW; Wands JR; Mezey E; Waterbury LA; Wright JR; Tobin J; Andres R
Medicine (Baltimore); 1977 May; 56(3):197-211. PubMed ID: 870791
[TBL] [Abstract][Full Text] [Related]
13. Disease-related conditions in relatives of patients with hemochromatosis.
Bulaj ZJ; Ajioka RS; Phillips JD; LaSalle BA; Jorde LB; Griffen LM; Edwards CQ; Kushner JP
N Engl J Med; 2000 Nov; 343(21):1529-35. PubMed ID: 11087882
[TBL] [Abstract][Full Text] [Related]
14. [Iron storage disease].
Horváth G; Dávid K
Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
[TBL] [Abstract][Full Text] [Related]
15. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
16. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.
Cruz E; Melo G; Lacerda R; Almeida S; Porto G
Blood Cells Mol Dis; 2006; 37(1):33-9. PubMed ID: 16762569
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation.
Shaheen NJ; Bacon BR; Grimm IS
Hepatology; 1998 Aug; 28(2):526-9. PubMed ID: 9696020
[TBL] [Abstract][Full Text] [Related]
18. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
Hicken BL; Tucker DC; Barton JC
Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
[TBL] [Abstract][Full Text] [Related]
19. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
20. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
de Diego C; Opazo S; Murga MJ; Martínez-Castro P
Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
